This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Articles

Introduction: Focus on Depression and Anxiety Disorders in General Medicine

James C. Ballenger, MD; Jonathan R. T. Davidson, MD; Yves Lecrubier, MD; and David J. Nutt, MD, PhD

Published: July 1, 2001

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

The fifth meeting of the International Consensus Group on Depression and Anxiety took as its subject the comorbidity of anxiety disorders and depression with T medical illness. The cornerstone of the Consensus Group’s mission is to increase the awareness and understanding of depression and anxiety disorders among clinicians and to improve the treatment of these conditions. This awareness is particularly relevant for the field of general medicine, in which physicians have identification and treatment of somatic symptoms as their main focus.

 

 


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 62

Quick Links: Anxiety , Anxiolytics

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Clinical and Practical Psychopharmacology

Antipsychotic Augmentation With N-Acetylcysteine for Patients With Schizophrenia

Dr Andrade discusses whether or not recent findings support the use of NAC as antipsychotic augmentation in...

Read More...